Patents
Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
03/1992
03/25/1992CN1059758A Non-a, non-b hepatitis virus particles
03/25/1992CA2052022A1 Peptides having thrombospondin-like activity and their therapeutic use
03/25/1992CA2051749A1 Cell adhesion molecule
03/24/1992US5099004 Antibodies such as monoclonal antibodies
03/24/1992US5099003 Method of preparing a sterile plasma-protein solution containing fibrinogen and factor xiii
03/24/1992US5099002 Sequential improved method for treatment of human blood-clotting factor products
03/24/1992US5099001 Process for the production of thyroglobulin
03/24/1992US5099000 Fluorescent compounds for immunoassay as tracers
03/24/1992US5098998 Protection against Vibrio
03/24/1992US5098997 Vaccines for Haemophilus influenzae
03/24/1992US5098995 GRF Analogs VIIA
03/24/1992US5098924 Hypotensive agents and angiotensin II inhibitors
03/24/1992US5098890 Antisence oligonucleotides to c-myb proto-oncogene and uses thereof
03/24/1992US5098887 Angiotensin converting enzyme inhibitor
03/24/1992US5098833 DNA sequence encoding a functional domain of a lymphocyte homing receptor
03/24/1992US5098829 Immunoadsorbents
03/24/1992US5098828 Immunoassay and testing
03/24/1992US5098826 Binding and detection of antigens
03/24/1992US5098722 Method of manufacturing iron-fortified beverage
03/24/1992US5098705 Bioinsecticides
03/24/1992US5098704 Hepatitis surface antigen particle vaccine
03/24/1992US5098703 Interferon-alpha 76
03/24/1992CA1298034C Amino acid derivatives
03/24/1992CA1298032C Method of preparing alpha-1-proteinase inhibitor
03/24/1992CA1297825C Antibiotics called "chloropolysporins b and c" a process for their preparation, and their therapeutic and veterinary use
03/24/1992CA1297819C Hybridoma tumor cell lines and their monoclonal antibodies to theumatin
03/24/1992CA1297816C Platelet function inhibiting monoclonal antibody fragment
03/24/1992CA1297815C Fibrinogen blocking monoclonal antibody
03/24/1992CA1297814C Process for production of insulin-like growth factor i and plasmid for production thereof
03/24/1992CA1297813C Process for production of insulin-like growth factor i
03/24/1992CA1297789C Treatment of bacterial diseases with granulocyte-macrophage colony stimulating factor
03/22/1992WO1992005444A1 Poly(fluoroalkyl) sugar reagents and their use for surface modification
03/22/1992WO1992005266A2 Packaging cells
03/22/1992WO1992004912A1 Composition for inducing granulocyte production or b cell production in peripheral blood
03/22/1992CA2091177A1 Poly(fluoroalkyl) sugar reagents and their use for surface modification
03/22/1992CA2051975A1 Polypeptide
03/22/1992CA2051974A1 Polypeptide
03/22/1992CA2051829A1 Gene encoding a 30-kilodalton outer membrane protein of bordetella pertussis
03/22/1992CA2051796A1 Vascular endothelial cell growth factor ii
03/21/1992CA2051721A1 Nasal pharmaceutical composition
03/20/1992WO1992004911A1 Substantially pure interleukin-9 receptor and uses thereof
03/19/1992WO1992005273A1 Gene therapy for cystic fibrosis
03/19/1992WO1992004632A1 Methods for the diagnosis and treatment of diabetes
03/19/1992WO1992004472A1 Antigens associated with polymyositis and with dermatomyositis
03/19/1992WO1992004461A1 Genetically engineered coccidiosis vaccine
03/19/1992WO1992004460A1 Genetically engineered coccidiosis vaccine
03/19/1992WO1992004454A1 Compounds and constructs for producing male sterile plants
03/19/1992WO1992004452A1 Transcription initiation regulating nucleotide sequence
03/19/1992WO1992004451A1 Promoter probe vectors, able to replicate in e.coli, b.subtilis, lactococci and lactobacillus as well as uses thereof
03/19/1992WO1992004446A1 Cloning of chicken anaemia dna
03/19/1992WO1992004445A1 Cloning and sequencing of allergens of dermatophagoides (house dust mite)
03/19/1992WO1992004442A1 Glial antiproliferative proteins
03/19/1992WO1992004380A1 Specific binding agents
03/19/1992WO1992004379A1 A new growth factor isolated from porcine spleen
03/19/1992WO1992004378A1 Recombinant agents affecting thrombosis
03/19/1992WO1992004376A1 Novel chemotactic factor
03/19/1992WO1992004375A1 Hrsv vaccine
03/19/1992WO1992004368A1 Pharmacologically active substance bpc, the process for its preparation and its use in the therapy
03/19/1992WO1992004366A1 Method and apparatus for the rapid synthesis of substrate-bound or free peptides or oligonucleotides, flat material synthesized in this way and the use of such material
03/19/1992WO1992004363A1 Production of insulin-like growth factor-1 in methylotrophic yeast cells
03/19/1992WO1992004050A1 Recombinant herpes simplex viruses vaccines and methods
03/19/1992WO1992004045A1 Novel cholecystokinin antagonists, their preparation and therapeutic use
03/19/1992WO1992004042A1 Glucagon analogs with asp9 replacements or deletions
03/19/1992WO1992004039A1 Regulation of cell proliferation and differentiation using peptides
03/19/1992WO1992004038A1 Pro-drugs for cck antagonists
03/19/1992WO1992004035A1 Anti-inflammatory factor, method of isolation, and use
03/19/1992WO1992003918A1 Transgenic non-human animals capable of producing heterologous antibodies
03/19/1992WO1992003917A1 Homologous recombination in mammalian cells
03/19/1992WO1992002612A3 Tissue plasminogen activator variants with decreased clearance
03/19/1992WO1991018981A3 Neurotropic growth factors comprising a homeobox peptide
03/19/1992EP0484508A4 Proteinaceous fat substitute.
03/19/1992DE4029227A1 Arzneimittel enthaltend cd14 Medicines containing CD14
03/19/1992CA2090473A1 Homologous recombinatin in mammalian cells
03/19/1992CA2090410A1 Antithrombosis agents
03/19/1992CA2090010A1 Nucleotidic sequence regulating the initiation of transcription
03/19/1992CA2088195A1 Cholecystokinin antagonists, their preparation and therapeutic use
03/18/1992WO1992005272A1 Method and composition for controlling proliferation of cells
03/18/1992WO1992005264A1 Multiple promoter baculovirus expression system and defective particle production
03/18/1992WO1992005191A1 Fungicidally active compounds
03/18/1992EP0475927A2 Method of somatotropin naturation
03/18/1992EP0475779A1 Process for the separation of proteins, polypeptides or metals using immobilized, optionally modified, phosvitin
03/18/1992EP0475746A1 Human and murine interleukin-5 receptor
03/18/1992EP0475719A2 Platelet derived growth regulating peptide
03/18/1992EP0475656A2 The use of Bacillus thuringiensis microbes for controlling the lesser mealworm Alphitobius diaperinus
03/18/1992EP0475623A1 Genetic mechanisms of tumor supression
03/18/1992EP0475584A2 Inactivation of gene transcription in plants using altered transcriptional activators
03/18/1992EP0475553A2 Life span determining protein and method of isolating the same
03/18/1992EP0475478A1 Haemophilus paragallinarum vaccine
03/18/1992EP0475394A2 Rat C-type natriuretic peptide cDNA and precursor protein
03/18/1992EP0475354A2 Sialysation of glycoproteins by genetic technology
03/18/1992EP0475311A1 Process for removing proteins originating from Escherichia coli
03/18/1992EP0475292A2 Human luteinizing hormone-human chorionic gonadotropin receptor (Human LH/hCG receptor)
03/18/1992EP0475291A1 A novel biologically active peptide derived from chicken (chicken CNP)
03/18/1992EP0475290A1 A novel biologically active peptide derived from frog (frog CNP)
03/18/1992EP0475230A1 Methods of conjugating actinomycin D
03/18/1992EP0475185A1 DNA's encoding surface antigen of mycoplasma hyopneumoniae, DNA fragments for primer, recombinant antigenic peptides and diagnostic method of mycoplasmal pneumoniae of swine using same
03/18/1992EP0475182A2 Method for protein synthesis using CKS fusion proteins
03/18/1992EP0474979A1 Heparin binding neurotrophic factor gene sequence
03/18/1992EP0474891A1 Vectors for expression of malarial antigens on the surface of Salmonella vaccine strains
03/18/1992EP0474868A1 Method of producing core structure of retro virus and particle produced thereby